MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Clin Epigenetics. 2022 Oct 15;14(1):130. doi: 10.1186/s13148-022-01351-2.
Ethnic differences in non-communicable disease risk have been described between individuals of South Asian and European ethnicity that are only partially explained by genetics and other known risk factors. DNA methylation is one underexplored mechanism that may explain differences in disease risk. Currently, there is little knowledge of how DNA methylation varies between South Asian and European ethnicities. This study characterised differences in blood DNA methylation between individuals of self-reported European and South Asian ethnicity from two UK-based cohorts: Southall and Brent Revisited and Born in Bradford. DNA methylation differences between ethnicities were widespread throughout the genome (n = 16,433 CpG sites, 3.4% sites tested). Specifically, 76% of associations were attributable to ethnic differences in cell composition with fewer effects attributable to smoking and genetic variation. Ethnicity-associated CpG sites were enriched for EWAS Catalog phenotypes including metabolites. This work highlights the need to consider ethnic diversity in epigenetic research.
南亚裔和欧洲裔个体之间存在非传染性疾病风险的种族差异,这些差异部分可以通过遗传和其他已知风险因素来解释。DNA 甲基化是一个尚未充分研究的机制,它可能可以解释疾病风险的差异。目前,关于南亚裔和欧洲裔个体之间的 DNA 甲基化如何变化,我们知之甚少。本研究对来自两个英国队列(南伦敦和布伦特再探和生于布拉德福德)的自我报告为欧洲裔和南亚裔个体的血液 DNA 甲基化差异进行了特征描述。种族间的 DNA 甲基化差异广泛存在于基因组中(n=16433 个 CpG 位点,3.4%的测试位点)。具体来说,76%的关联归因于细胞组成的种族差异,而吸烟和遗传变异的影响较小。与种族相关的 CpG 位点富集了 EWAS Catalog 表型,包括代谢物。这项工作强调了在表观遗传学研究中需要考虑种族多样性。